Cargando…
Ciclesonide: Oral candidiasis following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602457/ http://dx.doi.org/10.1007/s40278-021-05599-1 |
Ejemplares similares
-
Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022) -
Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report
Publicado: (2021) -
Ciclesonide/favipiravir/lopinavir/ritonavir: Off-label use, pancytopenia and liver dysfunction: case report
Publicado: (2021) -
Oral candidiasis caused by ciclesonide in a patient with COVID-19
pneumonia: A case report and literature review
por: Ohashi, Nobuhide, et al.
Publicado: (2021) -
Antibiotics/corticosteroids: Pneumonia following off-label use, oral pseudomembranous candidiasis, recurrent herpes labialis: case report
Publicado: (2022)